ANAB
AnaptysBioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ANAB vs peer average
54/100
ANAB vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Amgen is another broad biologics cash-flow comparator that helps anchor how the market rewards durable cash generation and shareholder returns, though it is not a direct operating match for ANAB's post-spin royalty profile.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANAB
AnaptysBio
AMGN
Amgen
Grade
C
D
Momentum
31
93
Value
49
61
Sentiment
66
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs AMGN
ANAB / AMGN
Grade Position
In line
ANAB vs. peer average (C vs. C)
54/100
Momentum
31
AMGNValue
49
AMGNSentiment
66
ANABRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANAB
AMGN is the first peer returned for this comparison set.